News Eversana, UpScriptHealth ally on digital patient platform UpScriptHealth has joined forces with Eversana on a digital platform that aims to improve patient access to therapies, and the experience that goes with it.
News Lilly strikes $1.9bn kidney disease alliance with Ascidian In its third big licensing deal of the week, Eli Lilly has tapped RNA-editing specialist Ascidian for kidney disease therapies in a $1.9bn alliance.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.